Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism

Reduced versus full apixaban lead-in dosing following parenteral treatment of acute venous thromboembolism

Saved in:

Bibliographic Details
Main Authors:	Daniella Veloria, Benjamin Wang, Ran Ran, David Ha, Robert Diep, Calvin Diep
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Thrombosis Update
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666572725000021
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
by: Marte Svalastoga, et al.
Published: (2025-01-01)

Venous thromboembolism still leads on maternal death
by: Amelia Shard, et al.
Published: (2025-01-01)

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP
by: Alessandro Laganà, et al.
Published: (2024-02-01)

Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
by: Olivia Wu, et al.
Published: (2022-01-01)

Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Maria I. Zervou, et al.
Published: (2025-02-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

Acute Pulmonary Embolism Associated with Low-Dose Olanzapine in a Patient without Risk Factors for Venous Thromboembolism
by: Vu Hoang Vu, et al.
Published: (2021-01-01)

Response to Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Bengt Zöller, et al.
Published: (2025-02-01)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
by: Roberto C. Montoya, et al.
Published: (2012-01-01)

Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy
by: Shalini Jain Bagaria, et al.
Published: (2011-01-01)

Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study
by: Ahmed El-Bardissy, et al.
Published: (2025-01-01)

Causal relationship between educational attainment and the occurrence of venous thromboembolism
by: Sitong Guo, et al.
Published: (2025-02-01)

Racial disparities in extended venous thromboembolism prophylaxis after hysterectomy.
by: Wenbo Wu, et al.
Published: (2025-01-01)

Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
by: Rafaela Vostatek, et al.
Published: (2024-12-01)

Parenteral Antibiotics Reduce Bifidobacteria Colonization and Diversity in Neonates
by: Séamus Hussey, et al.
Published: (2011-01-01)

Venous thromboembolism in bullous pemphigoid: current evidence and update on systematic review
by: Atheer G. Almutairi, et al.
Published: (2025-01-01)

HPLC Method Development and Validation for the Determination of Apixaban and Clopidogrel in Novel Fixed-Dose Combination Tablets
by: Ni’meh Al-Shami, et al.
Published: (2024-01-01)

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)

Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
by: Jonatan Ahrén, et al.
Published: (2025-03-01)

Risk of Venous Thromboembolism in Patients Nursed at Home or in Long-Term Care Residential Facilities
by: Guido Arpaia, et al.
Published: (2011-01-01)

Circulating, Extracellular Vesicle-Associated Tissue Factor in Cancer Patients with and without Venous Thromboembolism
by: Valentina Lami, et al.
Published: (2025-01-01)

Evaluation of Risk Factors of Venous Thromboembolism in Imam Sadiq Teaching Hospital at Babylon City
by: Intisar Mahdi Kadhim Almurshedi, et al.
Published: (2022-11-01)

Aftermath of Apixaban: Atypical Anticoagulation Aftereffect
by: Bhesh Karki, et al.
Published: (2022-01-01)

Risk factors for venous thromboembolism after hip arthroscopy: a systematic review and meta-analysis
by: Haoxuan Li, et al.
Published: (2025-02-01)

Frequency and treatment of venous thromboembolic events in patients with space-occupying brain infarction and decompressive craniectomy
by: Dominik Michalski, et al.

Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care
by: Luis Alberto García Rodríguez, et al.
Published: (2022-06-01)

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021
by: Jia Wang, et al.
Published: (2023-01-01)

Large Left Ventricular Thrombus in a Patient with Systemic and Venous Thromboembolism Secondary to Protein C and S Deficiency
by: Mohit Pahuja, et al.
Published: (2017-01-01)

Investigating the dual causative pathways linking immune cells and venous thromboembolism via Mendelian randomization analysis
by: Ning Qi, et al.
Published: (2025-01-01)

Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non‐Hodgkin Lymphoma Patients
by: Wen Li, et al.
Published: (2024-12-01)

The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
by: Anas S. Tresh, et al.
Published: (2025-01-01)

Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis
by: Yifang Zhang, et al.
Published: (2024-12-01)

Parenteral Nutrition in Liver Resection
by: Carlo Chiarla, et al.
Published: (2012-01-01)

Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01)

NGHIÊN CỨU PHƯƠNG PHÁP PHÂN LẬP TANSHINONE IIA TỪ ĐAN SÂM LÀM CHẤT ĐỐI CHIẾU
by: Trịnh Thị Điệp, et al.
Published: (2015-03-01)

Do Pathologic Fractures in Long Bone Following Bony Malignancy Increase the Risk of Venous Thromboembolism? A Comparative Study
by: Sanjay Kumar Rai, et al.
Published: (2024-01-01)

Survey of Perceptions and Practices among Canadian Gastroenterologists regarding the Prevention of Venous Thromboembolism for Hospitalized Inflammatory Bowel Disease Patients
by: Roshan Razik, et al.
Published: (2012-01-01)

General practitioner use of D-dimer in suspected venous thromboembolism: historical cohort study in one geographical region in the Netherlands
by: Angel M R Schols, et al.
Published: (2019-05-01)

Causal association between circulating α-Klotho levels and venous thromboembolism: a two-sample Mendelian randomization study
by: Yanmin Song, et al.
Published: (2025-01-01)